John F Stone
Overview
Explore the profile of John F Stone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Analytical Validation and Performance of a 7-Gene Next-Generation Sequencing Panel in Uveal Melanoma
Alsina K, Sholl L, Covington K, Arnal S, Durante M, Decatur C, et al.
Ocul Oncol Pathol
. 2022 Jan;
7(6):428-436.
PMID: 35083209
Introduction: Gene expression profiling (GEP) is widely used for prognostication in patients with uveal melanoma (UM). Because biopsy tissue is limited, it is critical to obtain as much genomic information...
2.
Cook R, Middlebrook B, Wilkinson J, Covington K, Oelschlager K, Monzon F, et al.
Diagn Pathol
. 2018 Feb;
13(1):13.
PMID: 29433548
Background: The DecisionDx-Melanoma test provides prognostic information for patients with cutaneous melanoma (CM). Using formalin-fixed paraffin-embedded primary tumor tissue, the RT-PCR-based test classifies patients into a low- (Class 1) or...
3.
Plasseraud K, Wilkinson J, Oelschlager K, Poteet T, Cook R, Stone J, et al.
Diagn Pathol
. 2017 Aug;
12(1):59.
PMID: 28778171
Background: A 15-gene expression profile test has been clinically validated and is widely utilized in newly diagnosed uveal melanoma (UM) patients to assess metastatic potential of the tumor. As most...
4.
De Rienzo A, Cook R, Wilkinson J, Gustafson C, Amin W, Johnson C, et al.
J Mol Diagn
. 2016 Nov;
19(1):65-71.
PMID: 27863259
A molecular test performed using fresh-frozen tissue was proposed for use in the prognosis of patients with pleural mesothelioma. The accuracy of the test and its properties was assessed under...
5.
Field M, Durante M, Decatur C, Tarlan B, Oelschlager K, Stone J, et al.
Oncotarget
. 2016 Aug;
7(37):59209-59219.
PMID: 27486988
Background: We previously identified PRAME as a biomarker for metastatic risk in Class 1 uveal melanomas. In this study, we sought to define a threshold value for positive PRAME expression...
6.
Gerami P, Cook R, Russell M, Wilkinson J, Amaria R, Gonzalez R, et al.
J Am Acad Dermatol
. 2015 Mar;
72(5):780-5.e3.
PMID: 25748297
Background: A gene expression profile (GEP) test able to accurately identify risk of metastasis for patients with cutaneous melanoma has been clinically validated. Objective: We aimed for assessment of the...
7.
Gerami P, Cook R, Wilkinson J, Russell M, Dhillon N, Amaria R, et al.
Clin Cancer Res
. 2015 Jan;
21(1):175-83.
PMID: 25564571
Purpose: The development of a genetic signature for the identification of high-risk cutaneous melanoma tumors would provide a valuable prognostic tool with value for stage I and II patients who...
8.
Gokmen-Polar Y, Cook R, Goswami C, Wilkinson J, Maetzold D, Stone J, et al.
PLoS One
. 2013 Jul;
8(7):e66047.
PMID: 23894276
Purpose: Thymoma represents one of the rarest of all malignancies. Stage and completeness of resection have been used to ascertain postoperative therapeutic strategies albeit with limited prognostic accuracy. A molecular...